chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient said she felt dizzy and had her blood pressure taken and it was really high so she went to emergency room and they couldn't find anything wrong. She went to her primary care physician and he was not sure if it could have been caused by the vaccine. She is to monitor her blood pressure with the possibility of increasing her blood pressure medication
Erythema, warmth enlarging around area of injection left deltoid since given 11/11.
vomited on day following vaccines (8/22) improved some within 2 days then vomiting bright red blood and clots on early AM 8/25, progressed to coffee ground emesis by 8am 8/25 and then developed melena. Admitted on 8/25, endoscopy done and no source of bleeding. Resolved within 1-2 days, discharged on 8/30.
Onset on nausea, stomach cramps which began approx. 4 hours, post vax, and continued into following day.
Patient was given 3rd dose on Pediarix on 12/15/2022.  She returned on 1/12/23 for Prevnar but received dose of prevnar and another dose of Pediarix.  Patient tolerated well. No treatment needed.
Headache, coughing, chest pain, fever day #11 status post smallpox.
Patient reported having vaccine reaction to J&J that she received on 4/8 at federal site. Sx are body aches, arm pain, fatigue and tiredness, cough, congestion, and runny nose. Patient went to PCP and was dx'd with upper resp infection, brought note to EH. Note from PCP clears her to RTW on 4/19. Patient is getting tested off-site 4/15 @ 11am, understands test must be PCR and she needs to fax or email results to EH before she can RTW. TM understands if EH receives neg results before 4/19 she should be clear to RTW. Patient was emailed self-iso instructions, mgr informed she is not clear to work at this time, pay code PTO.
no adverse event; Expired PROQUAD which was reconstituted with STERILE DILUENT was administered to Patient; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender.  The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent.   On 22-SEP-2022 at 1:30 p.m., the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) lot# U009259, expiration date: 19-SEP-2022 (strength, dose, dosage regimen, anatomical location, and route of administration were not provided) as prophylaxis (expired vaccine used). No adverse event was reported.
3 days post vax, the pt became dyspenic and hypoxic with bronchospasm. Shortness of breath started 2 days post vax. Possible viral pneumonia was developed. Currently the pt is experiencing dyspenia and wheezing. Lower lobe pneumonia.
The patient said he is feeling nauseous and he said he cannot see after some seconds and also felt dizzy. we called 911 meanwhile the patient said after 5-10 minutes he can see and he still feel nauseous. He didn't go to the hospital with the paramedics. After paramedics left he said he felt fine.
Myalgia. Arthralgia. Mild wheezing. All lasted about 12 hours and then resolved. No treatment.
fever of 104, nausea, achiness all over, flu-like sx w/in hrs of 2nd dose; Adm to the hosp on 7MAY94 for deydration & fever; Still hospitalized on 9MAY94;
p/vax pt exp a fever of 104.5;pt sought unspecified medical attention;
fainting; Severe stomach-flue like symptoms with diarrhea; Severe stomach-flue like symptoms with diarrhea; Aches/Body aches in core; Head-cold like symptoms with sinus pain; Head-cold like symptoms with sinus pain; fatigue; Wooziness; Body aches in core and legs; This is a spontaneous report received from a non-contactable consumer (patient). A 30-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0179), via an unspecified route of administration on 29Apr2021 (at age of 30 years old) as single dose for COVID-19 immunization. Medical history included known allergies: Sulfa drugs. There were no concomitant medications. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No COVID prior vaccination. No COVID tested post vaccination. The patient experienced Severe stomach-flue like symptoms with diarrhea, fainting, aches. Head-cold like symptoms with sinus pain, fatigue, wooziness. Body aches in core and legs. All events on 30Apr2021. No treatment received for all events. The outcome of the events was recovered in 2021.  No follow-up attempts are Possible. No further information is expected.
Patient has active COVID19 after being fully vaccinated with 2 doses of Moderna (jan & february 2021)
Swell, itchy (L) cm warm approximately 9x9 with triamcinolone. Became painful on 6/9/18.
I had the vaccine and still got shingles/suspected vaccination failure; Got shingles but a mild case was horrible- such intense itching; intense itching; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pruritus. On an unknown date, the outcome of the vaccination failure, shingles and pruritus were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pruritus to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 7-May-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The case was reported by patient. The patient had the vaccine and still got shingles but a very mild case. The patient stated even a mild case was horrible- such intense itching. The patient could not imagine how bad a full-blown case would be. Additional Supportive Information: This case was considered as suspected vaccination failure since details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles not given. The follow up would not be possible since no contact details provided.
Headache, Fatigue- on day 2 Bels Palsy- Day 4
No adverse affects reported; a second dose ofVAQTA was given on 3/29/2019 after the first dose was given on 1/3/2019.; This spontaneous report was received from a physician refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 03-JAN-2019, the patient was vaccinated with their firs dose of hepatitis a vaccine, inactivated(VAQTA) lot # R034339, expiration date 23-NOV-2019, (dose, frequency, route, vaccination site were not reported), for prophylaxis  On 29-MAR-2019, the patient was vaccinated with their second dose of hepatitis a vaccine, inactivated(VAQTA) lot # R034339, expiration date 23-NOV-2019, (dose, frequency, route, vaccination site were not reported), for prophylaxis.  No adverse affects reported.
Information has been received from a medical assistant referring to multiple unspecified patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On unknown dates in August 2015, these patients were vaccinated with improperly stored (Merck) PROQUAD (Lot# reported as L007320, expiration date: 03-SEP-2016, strength, dose and route unknown). There was no information about concomitant therapy. No adverse effects were reported. This is one of several reports received from the same reporter. Lot# L007320 is an invalid lot number for PROQUAD. Additional information has been requested.
Weird side effect that felt like my brain was jiggling inside my head; dizziness; slight trouble walking; This is a spontaneous report from a non-contactable consumer (patient). A 24-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 24 years of age), via an unspecified route of administration, administered in arm left on 30Apr2021 16:00 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for COVID-19 immunisation. Medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 dose 1 on an unspecified date for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant. The patient was not diagnosed with COVID-19 prior to vaccination. She has not been tested for COVID-19 since the vaccination. The patient experienced weird side effect that felt like her brain was jiggling inside her head, dizziness, and slight trouble walking, all on 01May2021. Further ADR description stated that the patient had weird side effect that felt like her brain was jiggling inside her head. This lasted for two days after her second dosage. It caused dizziness and slight trouble walking sometimes.  The outcome of 'felt like her brain was jiggling inside her head' was recovered on 03May2021 (for 2 days) while outcome of other events was recovered on an unspecified date.  No follow-up attempts are possible. Information about batch number cannot be obtained.
Abdomen began hurting the following morning around 7 AM. It felt different than hunger pain. It feels superficial. It hurts from the left lower ribs to the right lower ribs, and from the stomach down to belly button.; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 22Apr2021 at 13:30 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 06:30, the patient experienced abdomen began hurting the following morning around 07:00, felt different than hunger pain, it felts superficial and hurts from left lower ribs to right lower ribs and from the stomach down to belly button. There was a consistent pain that has been lasting for the past 2 hours, even after eating food. Food didn't provide relief. She had been drinking multiple 12 oz. cups of water throughout the day the past three days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. On 21Apr2021, the patient underwent saliva test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event abdomen pain was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Increased heart rate and blood pressure- it returned to within normal limits within the hour; dizziness and nausea from 4-10 PM; inability to sleep from 12-5 PM; Weakness and swelling of the arm over the course of 36 hours
blister on inner side halfway between shoulder and elbow about the size of a fifty cent piece appeared on 10/20/19, redness from shoulder to 2 inches from elbow appeared on 10/18/19, painful since 10/18/19
25JAN94 below inject site approx 1 1/2 -2 inches area is red, warm, swollen approx 4 inches x 3 inches;
Left deltoid swollen, red and warm to touch.  No fever or any other symptoms.  Hard knot on the arm Patient taken to ER and ABTX prescribed.  Arm symptoms improved.
Anemia, Periannal Abcess, Bakers Cyst both knees, Gout both knees
No additional adverse effect; Pharmacy Intern reports that on 1/27/2020, the dose ofMMR II was inadvertently administered by the intramuscular route instead of the subcutaneous route; This spontaneous report was received from pharmacy technician referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions and allergies.  On 27-JAN-2020, the patient was inadvertently administered by intramuscular route instead of the subcutaneous a measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) with lot number S014429 and expiration date on 09-MAY-2021, for prophylaxis (dose, dose number, and  anatomical injection site were not reported); which was reconstituted with sterile diluent (strength, dose, frequency, indication, lot number and expiration date were not reported) (incorrect route of product administration). No additional adverse effect.
Tonic seizure began at home. Patient brought to office by parent. Arrived unresponsive with unresponsive pupils. Temp 101.4. Received oxygen in office. Transferred to ER by ambulance. Patient was observed in ER. The following day was brought in for follow up and appeared fine but 2 hours later was brought in again by parents with tonic-clonic seizure which was treated with oxygen and rectal valium. Temp 102. First seizure lasted about 15 minutes. The second seizure lasted 15-20 minutes and resulted in hospital admission.
Patient received DTaP vaccine in (L) thigh. Patient developed fever of 102.8 degrees F (daycare reports), erythema and redness at site. Erythema and redness is localized to injection site and measures 3 1/2" x 2 5/8" in size.
Dizziness; Bone hurt; Nausea; Fever; Tiredness that wont go away; Nagging Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), BONE PAIN (Bone hurt), NAUSEA (Nausea), PYREXIA (Fever) and FATIGUE (Tiredness that wont go away) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy (medicines: Penicillin), Sulfonamide allergy (medicines: sulfadrug), Food allergy (Food: Horse radish), Fruit allergy (Food: apricots), Vertigo (Not just a few second to maybe two minutes it continues on all day and night.), Atopic dermatitis since 2017 and Hypercholesterolemia since 2013. Concomitant products included ROSUVASTATIN, EZETIMIBE and LORATADINE for an unknown indication.    On 06-Aug-2021 at 2:55 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced HEADACHE (Nagging Headache). On 07-Aug-2021, the patient experienced DIZZINESS (Dizziness), BONE PAIN (Bone hurt), NAUSEA (Nausea), PYREXIA (Fever) and FATIGUE (Tiredness that wont go away). At the time of the report, DIZZINESS (Dizziness), BONE PAIN (Bone hurt), NAUSEA (Nausea), PYREXIA (Fever), FATIGUE (Tiredness that wont go away) and HEADACHE (Nagging Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Aug-2021: Patient medical relevant history added, concomitant drugs added,event was added.
First shot 5/18/21, 6 months window is past; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 18th May 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable. Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter stated that the patient received first dose of Shingrix and had been AWOL (absent without leave) but now all of a sudden he wanted second shot of the series, the 6 months window was well past them. The reporter asked that what GlaxoSmithKline advice was. The follow-up would not possible, as no contact details were available.
Swollen arm; flushed face; headache; chills; fever; arm hurt to touch or sleep on; tired; shaking; This is a spontaneous report from a non-contactable consumer (patient).   A 75-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Right arm on 25Feb2021 10:00, at the age of 75-years-old, (Batch/Lot Number: EN6203) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included High cholesterol, drug allergy (cannot take statins due to side effect).  There were no concomitant medications.  The patient did not have COVID-19 prior the vaccination. On 26Feb2021 02:00, the patient experienced swollen arm, flushed face, headache, chills, fever, arm hurt to touch or sleep on, tired, and shaking. The patient was not tested for COVID-19 post vaccination. The outcome of the events was recovering. No treatment was received for the events.  No follow-up attempts are possible. No further information is expected.
24NOV98 rt arm @ Td site, 2 1/2" diameter red, raised, pinpoint rash-itched;DPH recommended;25NOV98 like-but bites behind ear back of neck were nodules lymph gland areas, h/a top of head to temples began 25NOV;fever 100.3;sore to touch;
For about 14+ hours after, my urine was thicker and a dark yellow in color, most of the time, a lot liker "the first one of the day."  Even with good hydration, there was still a light yellow color, not clear, as it should have been.  No pain, it smelled a little and I mention this as I've not seen it as a side-effect listed anywhere else.
Swelling, redness, pain and fever 12 hours after DTAP, measure 17x11 cm.
Both vaccines were given 4/18/23. Mom reported on 4/20/23 that his arm was red and in pain
Information has been received from a physician concerning a 4-month-old patient who was vaccinated PO with a 2mL second dose of Rotateq. Subsequently the patient experienced prolonged diarrhea and vomiting. Subsequently, the patient recovered. Additional information has been requested. This is in follow-up to report(s) previously submitted on 8/14/2007. Information has been received from a health professional concerning a 10-week-old female with no pre-existing allergies, birth defects, or medical conditions who on 09-MAY-2007 was vaccinated PO with the first (also reported as second) 2mL dose of ROTATEQ (Lot # 656382/0234U). Vomiting and diarrhea were noted to be illness at the time of vaccination. Concomitant therapy that day included a first dose of PEDIARIX (Lot # AC21B097AB) administered IM in the right arm, a first dose of PEDVAXHIB (Lot # 655076/1272F) administered IM in the left thigh, and a first dose of PREVNAR (LOt # B08692H) administered IM in the left thigh. On 09-MAY-2007 the patient experienced prolonged diarrhea and vomiting. On 12-MAY-2007, 4 days later, the patient recovered from prolonged diarrhea and vomiting. There were no relevant diagnostic tests or laboratory data. No additional information is expected.
This spontaneous report as received from a pharmacist refers to a 64 years old female patient. The patient was vaccinated with ZOSTAVAX on approximately 17-AUG-2012, "3 weeks go". Lot# and route were unspecified. On approximately 19-AUG-2012, "2-3 days after vaccination", the patient developed a spot on her arm and a spot on her chest. No medical treatment was prescribed. The outcome of patient was unknown. It was unspecified if the patient sought medical attention or not. Additional information has been requested.
Painful hives on my upper arm, same side as the shot. Lasted about a week. 8 weeks later there are still faint marks from the hives.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient. ON 05-AUG-2014 the patient was vaccinated with a d ose of ZOSTAVAX (dose, route, lot # and expiration date were not reported). Approximately in August 2014 the patient experienced injection site reaction: redness and swelling at the injection site of the ZOSTAVAX and unspecified period of   time after receiving ZOSTAVAX. The reporter believed that the injection site redness and swelling developed "within 2 days" of receiving ZOSTAVAX. The reporter was not aware of any treatment that was provided and he stated that there ws a nurse practitioner in her patient's family. ON Saturday 09-AUG_2014, the patient contacted the pharmacist and informed him that the injection sites of her were "okay" so the reporter believed that the injection site redness and swelling of the patient ws resolved and th patient recovered. The patient did not seek any medical attention. The relatedness between the event of "redness and swelling at the injection site" and ZOSTAVAX was not reported. This is the one of two reports received from the same reporter (MARRS#1408USA007708 the patient's husband case). Additional information has been requested.
Sunday afternoon, 10/23/05 (the day after receiving the flu shot) experienced extreme dizziness and nausea.  This started subsiding somewhat the next morning.  By Tuesday afternoon, 10/25/05, the symptoms were, for the most part, gone.  Very little appetite until afternoon of 10/25/05.
Adverse reaction began around midnight with chills, continued throughout the night alternating chills and hot flashes, severe backache, muscle aches in thighs and general malaise.  Got up around 8 to try to take a warm shower to ease muscle aches but as soon as I got into the bathroom I felt very hot, very nauseated and lightheaded.  I suspected hypotension but of course I wasn't able to prove it at the time. I attempted to get back to my bed but had syncopal episode a few feet from the bed where I collapsed onto the floor.  I just stayed on the floor and rested because it actually felt better lying down. I am a retired RN and suspect this adverse event was related to orthostatic hypotension.  Nothing like this has ever happened to me before.